AIM Rule 26

The information below is disclosed in accordance with Rule 26 of the AIM Rules for Companies and was last updated on 15th October 2018.

Business Description

Please click on the link below for a description of the business.
Investor Overview

Board of Directors

Please click on the link below for an overview of our senior team.
Board of Directors

Annual and Interim Reports

Please click on the link to access the Company's Annual and Interim Reports

Corporate Governance

Please click on the link for an overview of our Corporate Governance policies and procedures.

Main Country of Incorporation and Operations

The Company is incorporated in England and Wales, with a registered number 6227084.

Its main centre of operation is Oxford, UK, and has overseas operations in Malaysia and Singapore.

UK Takeover Code

The Company is subject to the UK City Code on Takeovers and Mergers.

Current constitutional documents

Please click on the link below for access to our Key Corporate Documents.

Details of any other exchanges or trading platforms

The Company’s shares are not traded on any other stock exchange.

The number of AIM securities in issue

The Company does not hold any Ordinary Shares in treasury and therefore the number of Ordinary Shares with voting rights is 92,559,771.

The percentage of AIM securities not in public hands is 33.9%. The identity and percentage holdings of significant shareholders as notified to the Company:

Name of Shareholder Number of Ordinary Shares Percentage of Issued Share Capital
Christian Hoyer Millar and Family 12,326,303 13.37%
Vulpes Life Sciences Fund 11,591,883 12.57%
Odey Funds 8,592,523 9.98%
The Chancellor, Masters and Scholars of the University of Oxford 6,360,529 6.90%
Alexandre Akoulitchev 6,153,082 6.67%
Aroul Ramadass and Family 5,830,468 6.32%
GL Healthcare Investment L.P. 4,688,000 5.08%
Jeremy Richard Chancellor Ironside 4,236,644 4.84%

Please submit TR1 notifications to investorrelations@oxfordbiodynamics.com

Details of any restrictions on the transfer of AIM securities

There are no restrictions on the transfer of the Company’s Ordinary Shares.

Regulatory news

Please click on the link below to access notifications made by the Company in the past five years.
Regulatory news

AIM admission document and circulars

Please click on the link below to access the Company's Admission Document and circulars or similar publications sent to shareholders within the past 12 months.
Key Corporate Documents

Advisors

Please click on the link below for details of the Company's Nominated Adviser and other key advisers.
Investor Contacts